ICON4/AGO-OVAR-2.2: Questions about trial design, cost-effectiveness, and clinical benefit [4] (multiple letters)

Keith Wheatley; Richard Gray; Geoff Newman; John A. Green; Nicoletta Colombo; Andreas Du Bois; Gunnar Kristensen; Jonathan Ledermann; Valter Torri

doi:10.1016/S0140-6736(03)14601-6

ICON4/AGO-OVAR-2.2: Questions about trial design, cost-effectiveness, and clinical benefit [4] (multiple letters)

Keith Wheatley, Richard Gray, Geoff Newman, John A. Green, Nicoletta Colombo, Andreas Du Bois, Gunnar Kristensen, Jonathan Ledermann, Valter Torri

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1333-1334
Number of pages	2
Journal	Lancet
Volume	362
Issue number	9392
DOIs	https://doi.org/10.1016/S0140-6736(03)14601-6
Publication status	Published - Oct 18 2003

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/S0140-6736(03)14601-6

Cite this

ICON4/AGO-OVAR-2.2 : Questions about trial design, cost-effectiveness, and clinical benefit [4] (multiple letters). / Wheatley, Keith; Gray, Richard; Newman, Geoff; Green, John A.; Colombo, Nicoletta; Du Bois, Andreas; Kristensen, Gunnar; Ledermann, Jonathan; Torri, Valter.

In: Lancet, Vol. 362, No. 9392, 18.10.2003, p. 1333-1334.

Research output: Contribution to journal › Article › peer-review

@article{c52daf45e60c42b2ab7d50607694703e,

title = "ICON4/AGO-OVAR-2.2: Questions about trial design, cost-effectiveness, and clinical benefit [4] (multiple letters)",

author = "Keith Wheatley and Richard Gray and Geoff Newman and Green, {John A.} and Nicoletta Colombo and {Du Bois}, Andreas and Gunnar Kristensen and Jonathan Ledermann and Valter Torri",

year = "2003",

month = oct,

day = "18",

doi = "10.1016/S0140-6736(03)14601-6",

language = "English",

volume = "362",

pages = "1333--1334",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Lancet Publishing Group",

number = "9392",

}

TY - JOUR

T1 - ICON4/AGO-OVAR-2.2

T2 - Questions about trial design, cost-effectiveness, and clinical benefit [4] (multiple letters)

AU - Wheatley, Keith

AU - Gray, Richard

AU - Newman, Geoff

AU - Green, John A.

AU - Colombo, Nicoletta

AU - Du Bois, Andreas

AU - Kristensen, Gunnar

AU - Ledermann, Jonathan

AU - Torri, Valter

PY - 2003/10/18

Y1 - 2003/10/18

UR - http://www.scopus.com/inward/record.url?scp=0142155203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142155203&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(03)14601-6

DO - 10.1016/S0140-6736(03)14601-6

M3 - Article

C2 - 14575996

AN - SCOPUS:0142155203

VL - 362

SP - 1333

EP - 1334

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9392

ER -

ICON4/AGO-OVAR-2.2: Questions about trial design, cost-effectiveness, and clinical benefit [4] (multiple letters)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this